CD8A and neoplasm: Here, we report that tumor cell‐derived ANGPTL2 contributes to tumor progression by accelerating epigenetic repression of MHC‐I expression in tumor cells, resulting in their evasion of CD8+ T‐cell‐mediated anti‐tumor immune responses.